EVOK — Evoke Income Statement
0.000.00%
- £214.35m
- £1.80bn
- £1.75bn
- 32
- 91
- 29
- 47
Annual income statement for Evoke, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 663 | 712 | 1,239 | 1,711 | 1,755 |
Cost of Revenue | |||||
Gross Profit | 439 | 463 | 794 | 1,132 | 1,151 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 637 | 649 | 1,251 | 1,687 | 1,755 |
Operating Profit | 25.6 | 63.2 | -11.8 | 24.2 | -0.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.8 | 59 | -116 | -130 | -169 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.81 | 50 | -121 | -65.2 | -191 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 8.81 | 49.9 | -121 | -65.2 | -192 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.81 | 49.9 | -121 | -65.2 | -192 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.185 | 0.171 | 0.001 | 0.054 | -0.206 |
Dividends per Share |